World Liquid Biopsy Market Report 2023-2027: Market Share Assessments, Competitive Research, and Due Diligence for M&As
Dublin, March 03, 2023 (GLOBE NEWSWIRE) -- The "The World Market for Liquid Biopsy, 2023" report has been added to ResearchAndMarkets.com's offering.
The World Liquid Biopsy Market, 2023, contains up-to-date information and useful data points for business planning
Dramatic changes have occurred in the liquid biopsy market, necessitating a resource to provide perspective on the market opportunity. This new report assesses the Liquid Biopsy Market now and in 2027.
The report can be useful for business planning, market share assessment, competitive research, and due diligence for mergers and acquisitions and other partnerships.
Liquid biopsy is gaining acceptance each year. Even through the COVID-19 pandemic, announcements of new liquid biopsy products were made and studies were conducted to assess the capability of these tests in clinical diagnostics uses.
While tissue biopsies and imaging techniques remain the current standards of care in the diagnosis of solid tumors, they have risks and limitations and limitations, some of which can be overcome by the use of liquid biopsy in clinical oncology, as an alternative or complementary technique to the current standards of care.
Liquid biopsy testing has many potential applications in aspects of clinical oncology, including:
Early detection and diagnosis/screening
Alternative testing method when tissue biopsy is difficult/impossible, or when the primary site of metastatic disease is unknown
Therapy personalization and monitoring - by molecular characterization of a patient's disease, clinicians can select the optimal course of therapy and monitor efficacy over time, as well as quickly react to adjust therapy should treatment resistance arise
Disease monitoring - to observe disease progression, tumor evolution, residual disease, and early detection of recurrence
These applications, increasing acceptance, the use of liquid biopsy in combination with other technologies. This report contains market assessments for these application categories.
Key Topics Covered:
Chapter One: Executive Summary
Introduction
Liquid Biopsy Technologies
Industry Structure
Liquid Biopsy Market Revenues And Forecast
Chapter Two: Liquid Biopsy Technologies
Introduction
Current Major Liquid Biopsy Technologies
Chapter Three: Circulating Tumor Dna (Ctdna) Liquid Biopsy
Introduction
Advantages And Limitations Of Ctdna In Liquid Biopsy
Current Ctdna-Based Liquid Biopsy Tests
Biocartis
Biocept
Biodesix
Cellmax Life
Circulogene
Diacarta
Epigenomics
Foundation Medicine (Roche)
Guardant Health
Inivata (Neogenomics)
Lunglife Ai
Myriad Genetics
Neogenomics
Oncodna
Personal Genomic Diagnostics
Qiagen
Resolution Biosciences
Roche Diagnostics
Sysmex-Inostics
Tempus
Ctdna-Based Liquid Biopsy Tests In Development
Exact Sciences
Freenome
Grail
Chapter Four: Circulating Tumor Cells (Ctcs) Liquid Biopsy
Introduction
Challenges In The Development Of Ctc-Based Liquid Biopsy Tests
Ctc-Based Liquid Biopsy Tests
Adaptive Biotechnologies
Angle
Biocept
Cellmax Life
Epic Sciences
Gilupi
Lunglife Ai
Menarini-Silicon Biosystems
Qiagen
Selected Ctc-Based Liquid Biopsy Tests In Development
Epic Sciences
Liquid Biotech Usa
Chapter Five: Extracellular Vesicles And Other Liquid Biopsy
Introduction
Liquid Biopsy Tests Based On Extracellular Vesicles / Other Analytes
Aspira Women'S Health (Formerly Vermillion)
Biodesix
Exosome Diagnostics
Hologic
Mdxhealth
Extracellular Vesicle/Other Analyte-Based Liquid Biopsy Tests In Development
Circulogene
Oncocyte
Resolution Biosciences
Volitionrx
Chapter Six: Multi-Analyte Liquid Biopsy Tests
Introduction
Liquid Biopsy Tests Based On Multiple Analytes
Biocept
Biodesix
Foundation Medicine (Roche)
Lunglife Ai
Neogenomics
Oncodna
Multiple Analyte-Based Liquid Biopsy Tests In Development
Exact Sciences
Freenome
Grail
Lunglife Ai
Chapter Seven: Liquid Biopsy Tests For Research Use Only
Introduction
Liquid Biopsy Tests For Research Use Only
Agena Bioscience
Diacarta
Exosome Diagnostics
Guardant Health
Natera
Qiagen
Chapter Eight: Liquid Biopsy Industry Analysis
Introduction
Tiers Of Competition
Competitive Factors
Significant Market Trends
Personalized Medicine
Increasing Global Life Expectancy
New Liquid Biopsy Products
Increasing Accessibility Of Genetic Testing
Regulatory Hurdles
Third-Party Payor Coverage
Demonstrated Clinical Utility
Incidence Rates Of Specific Cancers
Competitors No Longer In The Liquid Biopsy Market
Chapter Nine: Liquid Biopsy Market
Market Overview
Market Forecast
Chapter Ten: Market By Analyte
Circulating Tumor Dna
Market Overview
Applications
Technologies
Specimens
Revenue Forecast
Circulating Tumor Cells
Market Overview
Applications
Technologies
Specimens
Revenue Forecast
Extracellular Vesicles And Other Analytes
Market Overview
Applications
Technologies
Specimens
Revenue Forecast
Multiple Analytes
Market Overview
Revenue Forecast
Chapter Eleven: Market By Application
Therapy Guidance And Monitoring
Market Overview
Revenue Forecast
Diagnosis/Screening
Market Overview
Revenue Forecast
Disease Prognosis
Market Overview
Revenue Forecast
Chapter Twelve: Market By Cancer Type
Breast Cancer
Market Overview
Revenue Forecast
Colorectal Cancer
Lung Cancer
Ovarian Cancer
Prostate Cancer
Other Cancers
Pan-Cancer Tests
Chapter Thirteen: Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/w064py
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
